Neutrophil function is impaired in paediatric patients with malignancy and may be a useful clinical marker

Jesus Reine Gutierrez, K. Cooper, A. Sewell, J. Lyall, C. Thorbinson, E. Hincks, Daniela Ferreira, B. Pizer, Benjamin Morton

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Purpose

Patients treated with cytotoxic chemotherapy are at risk of neutropenia, neutropenic fever and neutropenic sepsis. We hypothesised that pre-existing neutrophil function dysfunction may increase susceptibility to neutropenic fever in paediatric patients receiving cytotoxic chemotherapy.

Methods

Prospective cohort study recruited patients at Alder Hey Children’s NHS Foundation Trust, United Kingdom. We measured neutrophil phagocytic function using a validated flow cytometric whole blood phagocytosis assay in paediatric patients (n = 16) with oncological disease before and after chemotherapy in a prospective cohort study. We recruited healthy children as a control comparator (n = 10).

Results

We found significantly decreased phagocytic function in oncology patients compared to healthy participants. In five patients who developed neutropenic fever, we observed increased pre-dose neutrophil respiratory burst.

Conclusion

With further validation, measurement of neutrophil function could potentially be used to personalise appropriate prophylactic antimicrobial administration for patients receiving cytotoxic chemotherapy.

Original languageEnglish
Pages (from-to)2121-2125
Number of pages5
JournalClinical and Translational Oncology
Volume22
Issue number11
Early online date14 May 2020
DOIs
Publication statusPublished - 1 Nov 2020

Keywords

  • Biomarker
  • Cytotoxic chemotherapy
  • Flow cytometry
  • Neutrophils
  • Paediatric cancer
  • Phagocytosis

Fingerprint

Dive into the research topics of 'Neutrophil function is impaired in paediatric patients with malignancy and may be a useful clinical marker'. Together they form a unique fingerprint.

Cite this